Abstract
Purpose
References
Table 1.
| Men | Women | P-value5) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total (n = 317) | MetS3) (n = 185) | Control (n = 132) | P-value4) | Total (n = 297) | MetS3) (n = 121) | Control (n = 176) | P-value4) | ||
| Age (years)1) | 45.4 ± 7.9 | 45.4 ± 7.6 | 45.4 ± 8.3 | 0.9794 | 48.2 ± 7.2 | 49.0 ± 7.2 | 47.7 ± 7.1 | 0.1156 | < 0.0001 |
| BMI (kg/m2)1) | 26.4 ± 2.8 | 27.0 ± 2.9 | 25.6 ± 2.5 | < 0.0001 | 24.9 ± 3.4 | 26.2 ± 2.9 | 24.0 ± 3.5 | < 0.0001 | < 0.0001 |
| Smoking status (yes)2) | 136 (42.9) | 84 (45.4) | 52 (39.4) | 0.2864 | 8 (2.7) | 1 (0.8) | 7 (4.0) | 0.0994 | < 0.0001 |
| Alcohol consumption (yes)2)6) | 149 (47.0) | 95 (51.4) | 54 (40.9) | 0.0663 | 30 (10.1) | 13 (10.7) | 17 (9.7) | 0.7605 | < 0.0001 |
| Physical activity (yes)2)7) | 71 (22.4) | 43 (23.2) | 28 (21.2) | 0.6846 | 51 (17.2) | 21 (17.4) | 30 (17.1) | 1.0000 | 0.1049 |
| Metabolic syndrome risk factors2) | |||||||||
| Abdominal obesity8) | 173 (54.6) | 129 (69.7) | 44 (33.3) | < 0.0001 | 192 (64.7) | 107 (88.4) | 85 (48.3) | < 0.0001 | 0.0111 |
| Hypertriglyceridemia9) | 244 (77.0) | 169 (91.4) | 75 (56.8) | < 0.0001 | 117 (39.4) | 75 (62.0) | 42 (23.9) | < 0.0001 | < 0.0001 |
| Low HDL-cholesterol10) | 95 (30.0) | 70 (37.8) | 25 (18.9) | 0.0003 | 129 (43.4) | 80 (66.1) | 49 (27.8) | < 0.0001 | 0.0005 |
| Elevated blood pressure11) | 218 (68.8) | 150 (81.1) | 68 (51.5) | < 0.0001 | 147 (49.5) | 87 (71.9) | 60 (34.1) | < 0.0001 | < 0.0001 |
| High fasting blood glucose12) | 155 (48.9) | 116 (62.7) | 39 (29.6) | < 0.0001 | 78 (26.3) | 52 (43.0) | 26 (14.8) | < 0.0001 | < 0.0001 |
3) MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria with a modified waist circumference cutoff for Asian populations provided by the International Diabetes Federation.
4) P-values for the difference between MetS group and control group, obtained by chi-square test for categorical variables and t-test for continuous variables.
5) P-values for the difference between total men and total women, obtained by chi-square test for categorical variables and t-test for continuous variables.
Table 2.
| Men | Women | P-value4) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Total (n = 317) | MetS2) (n = 185) | Control (n = 132) | P-value3) | Total (n = 297) | MetS2) (n = 121) | Control (n = 176) | P-value3) | ||
| Nutrient intake1) | |||||||||
| Energy (kcal) | 1,959.3 ± 507.6 | 1,967.5 ± 512.5 | 1,947.8 ± 502.4 | 0.7335 | 1,559.2 ± 475.7 | 1,561.5 ± 534.2 | 1,557.6 ± 432.5 | 0.9461 | < 0.0001 |
| Protein (g) | 80.1 ± 27.0 | 79.3 ± 24.9 | 81.2 ± 29.8 | 0.5384 | 62.8 ± 24.8 | 62.2 ± 26.9 | 63.3 ± 23.3 | 0.7074 | < 0.0001 |
| Lipid (g) | 49.4 ± 19.6 | 48.9 ± 18.7 | 50.1 ± 20.8 | 0.5760 | 40.2 ± 19.2 | 39.0 ± 20.1 | 41.0 ± 18.5 | 0.3855 | < 0.0001 |
| Carbohydrate (g) | 273.9 ± 71.4 | 270.5 ± 69.2 | 278.8 ± 74.5 | 0.3061 | 236.9 ± 73.4 | 243.5 ± 81.0 | 232.3 ± 67.6 | 0.2144 | < 0.0001 |
| Vitamin A (μg RE) | 712.5 ± 469.4 | 711.5 ± 552.9 | 714.0 ± 319.6 | 0.9586 | 670.7 ± 413.6 | 661.2 ± 407.3 | 677.2 ± 418.9 | 0.7435 | 0.2408 |
| Vitamin A (μg RAE) | 413.9 ± 259.2 | 408.5 ± 300.4 | 421.6 ± 187.6 | 0.6340 | 386.2 ± 237.5 | 380.3 ± 241.8 | 390.3 ± 235.0 | 0.7222 | 0.1685 |
| Retinol (μg) | 115.4 ± 122.0 | 105.5 ± 125.1 | 129.1 ± 116.5 | 0.0892 | 101.8 ± 129.7 | 99.4 ± 139.8 | 103.4 ± 122.7 | 0.7961 | 0.1822 |
| Carotenoids (μg) | 8,866.6 ± 7,971.8 | 8,628.7 ± 8,833.1 | 9,200.0 ± 6,596.3 | 0.5103 | 9,123.8 ± 7,863.2 | 8,939.5 ± 7,828.0 | 9,250.5 ± 7907.0 | 0.7383 | 0.6877 |
| Vitamin C (mg) | 78.1 ± 62.0 | 77.9 ± 67.9 | 78.4 ± 53.0 | 0.9430 | 84.5 ± 64.3 | 91.0 ± 69.6 | 80.1 ± 60.2 | 0.1529 | 0.2083 |
| Vitamin E (mg α-TE) | 6.5 ± 2.3 | 6.4 ± 2.4 | 6.6 ± 2.2 | 0.3098 | 5.6 ± 2.4 | 6.0 ± 2.8 | 5.4 ± 2.1 | 0.0649 | < 0.0001 |
| Nutrient density1) | |||||||||
| Protein (g/1,000 kcal) | 40.8 ± 8.4 | 40.3 ± 7.6 | 41.5 ± 9.5 | 0.2266 | 40.1 ± 9.3 | 39.7 ± 10.8 | 40.4 ± 8.2 | 0.5653 | 0.3235 |
| Lipid (g/1,000 kcal) | 24.9 ± 6.4 | 24.6 ± 6.4 | 25.4 ± 6.5 | 0.3380 | 25.2 ± 7.5 | 24.3 ± 6.9 | 25.9 ± 7.8 | 0.0699 | 0.6010 |
| Carbohydrate (g/1,000 kcal) | 142.3 ± 25.8 | 140.2 ± 25.8 | 145.4 ± 25.7 | 0.0768 | 153.6 ± 22.7 | 158.1 ± 23.1 | 150.6 ± 21.9 | 0.0049 | < 0.0001 |
| Vitamin A (μg RE/1,000 kcal) | 363.8 ± 177.9 | 355.7 ± 182.7 | 375.2 ± 170.9 | 0.3372 | 438.7 ± 272.3 | 437.0 ± 274.6 | 439.9 ± 271.5 | 0.9304 | < 0.0001 |
| Vitamin A (μg RAE/1,000 kcal) | 211.5 ± 101.1 | 204.7 ± 102.7 | 221.2 ± 98.2 | 0.1524 | 252.4 ± 156.6 | 252.0 ± 171.6 | 252.7 ± 146.0 | 0.9673 | 0.0002 |
| Retinol (μg/1,000 kcal) | 59.2 ± 59.6 | 53.6 ± 59.0 | 67.1 ± 59.7 | 0.0466 | 66.1 ± 90.4 | 66.9 ± 116.4 | 65.6 ± 67.3 | 0.9122 | 0.2661 |
| Carotenoids (μg/1,000 kcal) | 4,614.0 ± 4,252.7 | 4,432.3 ± 4,374.5 | 4,868.6 ± 4,078.7 | 0.3687 | 6,039.8 ± 5,225.1 | 5,993.8 ± 5,139.1 | 6,071.4 ± 5,297.8 | 0.9001 | 0.0002 |
| Vitamin C (mg/1,000 kcal) | 40.1 ± 28.9 | 39.4 ± 30.0 | 41.1 ± 27.4 | 0.6167 | 55.6 ± 39.3 | 60.4 ± 42.7 | 52.4 ± 36.5 | 0.0843 | < 0.0001 |
| Vitamin E (mg α-TE/1,000 kcal) | 3.3 ± 1.0 | 3.3 ± 1.0 | 3.5 ± 1.0 | 0.0731 | 3.6 ± 1.2 | 3.8 ± 1.4 | 3.5 ± 1.1 | 0.0297 | 0.0018 |
Table 3.
1) Waist circumference ≥ 90 cm (men) or ≥ 80 cm (women) 2) Fasting triglyceride ≥ 150 μg/dL 3) Fasting HDL-cholesterol < 40 μg/dL (men) or < 50 μg/dL (women) 4) Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg 5) Fasting blood glucose ≥ 100 μg/dL 6) MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria with a modified waist circumference cutoff for Asian populations provided by the International Diabetes Federation. 7) ORs, 95% CIs, and P for trends were adjusted for age, smoking status, alcohol consumption and physical activity. 8) ORs, 95% CIs, and P for trends were adjusted for age, smoking status, alcohol consumption, physical activity and BMI. 9) P-values were from generalized linear model analysis.
Table 4.
1) Values are mean ± SD. 2) MetS was defined using the National Cholesterol Education Program Adult Treatment Panel III criteria with a modified waist circumference cutoff for Asian populations provided by the International Diabetes Federation. 3) The value in the MetS group is significantly different from that of the control group at



PDF
ePub
Citation
Print


XML Download